Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

Risultato della ricerca: Contributo in rivistaArticolo

235 Citazioni (Scopus)

Abstract

N/A
Lingua originaleInglese
pagine (da-a)h1618-h1618
RivistaBMJ
Volume350
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Aspirin
  • Combined Modality Therapy
  • Coronary Artery Disease
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Drug-Eluting Stents
  • Hemorrhage
  • Humans
  • Models, Statistical
  • Myocardial Infarction
  • Percutaneous Coronary Intervention
  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Fingerprint

Entra nei temi di ricerca di 'Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials'. Insieme formano una fingerprint unica.

Cita questo